Case Report: Preemptive Treatment With Low-Dose PD-1 Blockade and Azacitidine for Molecular Relapsed Acute Myeloid Leukemia With RUNX1-RUNX1T1 After Allogeneic Hematopoietic Stem Cell Transplantation

Acute myeloid leukemia (AML) patients who develop hematological relapse (HR) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) generally have dismal clinical outcomes. Measurable residual disease (MRD)-directed preemptive interventions are effective approaches to prevent disease p...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Yutong, Zhou, Zhenyang, Yan, Han, You, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847388/
https://www.ncbi.nlm.nih.gov/pubmed/35185899
http://dx.doi.org/10.3389/fimmu.2022.810284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847388/
https://www.ncbi.nlm.nih.gov/pubmed/35185899
http://dx.doi.org/10.3389/fimmu.2022.810284

Ejemplares similares